Torrey Pines Law Group's attorneys and regulatory advisors have substantial experience providing strategic advice with respect to drug and medical device labeling, advertising and promotion.
Our team has helped clients in this increasingly complex legal and regulatory landscape in which advertising claims are scrutinized by foreign, federal, and state governments. In the US, our attorneys and advisors have experience with litigation, developing legal opinions, and advising clients related to Lanham Act false advertising, unfair competition, FDA labeling rules, Stark Laws, Anti-Kickback, trademark, copyright, rights of publicity, and federal privacy and data security (e.g., HIPAA and GDPR).
Torrey Pines Law Group, PC serves technology innovators with protecting intellectual property, obtaining regulatory approvals and clearances, and making deals and closing technology transactions throughout the U.S., including in major technology hubs such as San Diego, San Francisco, Palo Alto, San Jose, Silicon Valley, Boston, Cambridge, Chicago, Minneapolis, Houston, Dallas, Atlanta, Denver, Seattle, Portland, Boulder, Orlando, the Research Triangle (Raleigh, Durham, and Chapel Hill), the Mid-Atlantic (New Jersey, New York, Philadelphia, Maryland, Virginia, and Washington, DC), Pittsburgh, Cleveland, Ann Arbor, and throughout Southern California in Los Angeles, Orange County, Irvine, Torrey Pines, Sorrento Valley, and La Jolla.
We have experience with international intellectual property, regulatory and transactional matters pending in Beijing, Shanghai, Shenzhen, and Guangzhou China; Tokyo, Japan; Berlin, Munich and Frankfurt Gemany; Tel Aviv Israel; Mumbai, Bengaluru, and New Delhi India; London and Edinburgh United Kingdom; Vancouver, Toronto, Calgary and Montreal Canada; Dublin, Ireland; Cape Town, South Africa; Mexico City and Tijuana Mexico; Brussels, Belgium; Copenhagen, Denmark; Paris, France; Madrid and Barcelona Spain; Moscow, Russia; Santiago, Chile; Montevideo, Uruguay; Buenos Aires, Argentina; Sao Paulo and Rio de Janeiro Brazil; Seoul, South Korea; Taipei, Taiwan; Hong Kong; Hanoi, Vietnam; Bangkok, Thailand; Kuala Lumpur, Malaysia; Milan, Italy; Singapore; Sydney, Melbourne, Perth and Adelaide Australia; Auckland, New Zealand; Oslo, Norway; Stockholm, Sweden; Helsinki, Finland; Kiev, Ukraine; Budapest, Hungary; Vienna, Austria; Prague, Czechia; Geneva and Lausanne Switzerland; Bahrain; Doha, Qatar; Abu Dhabi and Dubai UAE; and Jeddah, Saudi Arabia.
San Diego Labeling Law Firm - Orange County Advertising Counsel - Los Angeles Commercialization Transactions - International Regulatory Advisors - Complex Promotions Transactions - Trademark Due Diligence Attorneys - Biotechnology Labeling Transactions Lawyers - Pharmaceutical Advertising Advisors - Medical Device Advertisements - Artificial Intelligence (AI) Advertising